Welcome to our dedicated page for Research Solutions SEC filings (Ticker: RSSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to decode how much Research Solutions earns from Article Galaxy subscriptions versus one-off article transactions? Or maybe you’d like an alert the moment a Form 4 shows a director buying stock after a new AI add-on launch. Investors come to this page because RSSS filings mix SaaS metrics, content-licensing costs, and acquisition accounting—often in well over 100 pages of disclosures.
Stock Titan’s AI reads every Research Solutions SEC document the instant it hits EDGAR and delivers what professionals ask for most:
- Real-time Research Solutions insider trading Form 4 transactions alongside concise explanations of each executive move.
- Clean summaries of every Research Solutions quarterly earnings report 10-Q filing, highlighting ARR growth, churn, and platform vs. transaction revenue.
- One-click access to the Research Solutions annual report 10-K simplified with AI call-outs for goodwill from the scite and ResoluteAI deals.
- Instant alerts when an 8-K material event is filed—from new content partnerships to CFO transitions—plus context on why it matters.
Need to understand deferred revenue tables, stock-based compensation, or proxy statement executive compensation details? Our AI-powered summaries translate accounting language into plain English, so you can focus on questions like “How will new AI modules lift gross margin?” rather than scrolling through footnotes. In short, this page is the fastest route to understanding Research Solutions SEC documents with AI—from insider stock moves to earnings trends—without getting lost in technical jargon.
Research Solutions, Inc. (RSSS)November 12, 2025, the director was granted an option to purchase 50,000 shares of common stock at an exercise price of $3.07 per share, expiring on November 11, 2035. The option was acquired as a direct holding with no cash price for the derivative itself. The vesting schedule provides that one-third of the options vest on November 12, 2026, and one-twelfth vest on the last day of each quarter beginning December 31, 2026 until fully vested.
Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant to purchase 50,000 shares of common stock on 11/12/2025. The stock options have an exercise price of $3.07 per share and expire on 11/11/2035. According to the vesting schedule, one-third of the options vest on November 12, 2026, with the remaining options vesting in equal quarterly installments on the last day of each quarter beginning December 31, 2026 until fully vested. The options are held as direct ownership by the reporting person.
Research Solutions, Inc. reported a stronger quarter for the period ended September 30, 2025. Revenue rose to
Net income increased to
The company continued settling the Scite acquisition earnout: a first payment in August 2025 included
Research Solutions, Inc. reported stockholder voting results from its November 12, 2025 annual meeting. Of 32,821,783 shares entitled to vote, 24,873,088 were represented (75.78%).
Stockholders cast votes for six director nominees, with “For” votes ranging from 17,148,886 to 17,846,193. The appointment of Wipfli LLP as independent accountants for the year ending June 30, 2026 received 24,841,816 “For,” 20,420 “Against,” and 10,852 “Abstain.” The advisory vote on executive compensation received 17,844,026 “For,” 26,733 “Against,” 62,956 “Abstain,” and 6,939,373 broker non-votes. On say‑on‑pay frequency, votes were 17,832,593 for 1 year, 1,557 for 2 years, 78,131 for 3 years, and 21,434 abstentions.
William Nurthen, Chief Financial Officer and Secretary of Research Solutions, Inc. (RSSS), reported a transaction dated 09/19/2025 in which he surrendered 2,225 shares of the company’s common stock to the issuer to cover taxes on vested restricted stock at an effective price of $3.66 per share. After the surrender, he beneficially owned 378,382 shares. The filing is signed by Mr. Nurthen on 09/26/2025. The explanation states the share surrender was approved by the Compensation Committee.
Research Solutions, Inc. insider share surrender to cover taxes
CEO & President Olivier Roy W reported a Form 4 disclosing a non-derivative transaction on 09/19/2025 in which 1,428 shares of Research Solutions, Inc. (RSSS) were disposed of at a price of $3.66 per share. The filing states these shares were surrendered to the company to cover taxes on vested restricted stock as approved by the Compensation Committee. After the transaction the reporting person beneficially owned 606,825 shares. The transaction appears to be a routine tax-withholding action tied to equity compensation rather than an open-market sale.
Research Solutions, Inc. filed a definitive proxy soliciting votes at its virtual 2025 Annual Meeting on matters including the election of six directors, ratification of Wipfli LLP as independent auditors for the fiscal year ending June 30, 2026, a non-binding advisory vote on executive compensation and a separate non-binding vote on the frequency of that advisory vote (the board recommends every 1 YEAR).
Voting methods include Internet, telephone or mail with votes due by 11:59 p.m. Eastern on November 11, 2025; virtual attendance requires a 16-digit control number. The proxy discloses executive pay design: a meaningful portion of annual incentive pay is performance-based (for fiscal 2025 between 17% and 43% of total AIP tied to measurable goals; CEO and CFO had 40% and 37% of AIP tied to objectives) and links payouts to net ARR growth and adjusted EBITDA. The filing lists material equity grants (e.g., 50,000, 340,000 restricted shares) and outstanding option pools with multiple strike prices. It also discloses a large institutional holding by Needham Investors (~1,700,000 shares per a 13F).
Research Solutions, Inc. (RSSS) discloses operational and balance sheet details in its Form 10-K. The company reports 32,479,993 shares issued and outstanding and cites a market value figure of $125,316,583 based on a closing price of $4.15. Reprints Desk holds $426,658 and $630,680 in bank accounts at June 30, 2025 and 2024, respectively. The allowance for doubtful accounts increased to $182,324 from $68,579, with provisions of about $163,000 in 2025. The company retains a $500,000 secured revolving credit facility (no borrowings outstanding). Acquisition-related items include contingent consideration and earnouts: an earnout had an initial fair value of $1.9 million, revalued to $0 at June 30, 2024, while unpaid contingent consideration of $31,359 and Bonus Amount payments of $124,107 were recorded in 2025. Product descriptions emphasize the Article Galaxy platforms and royalty/rights management for research customers.
FAQ
What is the current stock price of Research Solutions (RSSS)?
What is the market cap of Research Solutions (RSSS)?
